263 related articles for article (PubMed ID: 18643920)
1. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
Chai HC; Tay ST
Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
[TBL] [Abstract][Full Text] [Related]
2. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.
Abadi J; Pirofski La
J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394
[TBL] [Abstract][Full Text] [Related]
3. Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
Lamura L; Matthews RC; Barchiesi F; Donahoe M; Burnie JP; Scalise G
J Infect; 2000 Jan; 40(1):64-8. PubMed ID: 10762114
[TBL] [Abstract][Full Text] [Related]
4. Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.
Gressler AE; Volke D; Firacative C; Schnabel CL; Müller U; Krizsan A; Schulze-Richter B; Brock M; Brombacher F; Escandón P; Hoffmann R; Alber G
Front Immunol; 2021; 12():709695. PubMed ID: 34367172
[No Abstract] [Full Text] [Related]
5. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
Lin TY; Yeh KM; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2009 Jun; 42(3):220-6. PubMed ID: 19812855
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects.
Speed BR; Kaldor J; Cairns B; Pegorer M
J Med Vet Mycol; 1996; 34(3):187-93. PubMed ID: 8803799
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype.
Lendvai N; Casadevall A
J Infect Dis; 1999 Sep; 180(3):791-801. PubMed ID: 10438368
[TBL] [Abstract][Full Text] [Related]
8. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
Parra C; González JM; Castañeda E; Fiorentino S
Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to Cryptococcus neoformans proteins in rodents and humans.
Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A
Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877
[TBL] [Abstract][Full Text] [Related]
10. Disseminated cryptococcosis and histoplasmosis co-infection in a HIV-infected woman in France.
Ferry T; Ponceau B; Gaultier JB; Piens MA; Biron F; Picot S; Chidiac C; Peyramond D
J Infect; 2005 Oct; 51(3):e173-6. PubMed ID: 16230201
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of Cryptococcus neoformans serotypes associated with human infections in Argentina].
Canteros CE; Brudny M; Rodero L; Perrotta D; Davel G
Rev Argent Microbiol; 2002; 34(4):213-8. PubMed ID: 12600005
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.
Saha DC; Xess I; Zeng WY; Goldman DL
Med Mycol; 2008 Aug; 46(5):457-63. PubMed ID: 18608912
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.
Maitta RW; Datta K; Pirofski LA
Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis, immunobiology and epidemiology of cryptococcosis].
Müller J
Mycoses; 1994; 37 Suppl 1():34-42. PubMed ID: 7854364
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two novel cryptococcal mannoproteins recognized by immune sera.
Biondo C; Messina L; Bombaci M; Mancuso G; Midiri A; Beninati C; Cusumano V; Gerace E; Papasergi S; Teti G
Infect Immun; 2005 Nov; 73(11):7348-55. PubMed ID: 16239533
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia.
Becerra-Álvarez P; Escandón P; Lizarazo J; Quirós-Gómez Ó; Firacative C
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36066645
[TBL] [Abstract][Full Text] [Related]
17. Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.
Reiss E; Cherniak R; Eby R; Kaufman L
Diagn Immunol; 1984; 2(2):109-15. PubMed ID: 6388977
[TBL] [Abstract][Full Text] [Related]
18. [Clinical course of cryptococcosis in HIV infection].
Rakhmanova AG; Giaurgieva OKh
Klin Med (Mosk); 1999; 77(1):39-42. PubMed ID: 10097505
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal peritonitis as the first AIDS-defining illness in Zimbabwe.
Ferrand RA; Maunganidze AJ; Mgodi NM
Trop Doct; 2006 Oct; 36(4):249-50. PubMed ID: 17034711
[No Abstract] [Full Text] [Related]
20. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.
Kakeya H; Udono H; Maesaki S; Sasaki E; Kawamura S; Hossain MA; Yamamoto Y; Sawai T; Fukuda M; Mitsutake K; Miyazaki Y; Tomono K; Tashiro T; Nakayama E; Kohno S
Clin Exp Immunol; 1999 Mar; 115(3):485-90. PubMed ID: 10193422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
